Sutro Biopharma Company
Sutro Biopharma develops protein therapeutics by using OCFS protein synthesis technology.
Headquarters:
South San Francisco, California, United States
Industry:
Women Cancer Treatment
Employee Number:
51-100
Estimated Revenue:
$10M to $50M
Funding Status:
IPO
Technology:
Biologics
Last Funding Type:
Post-IPO Equity
Founded Date:
2003
Total Funding:
$347 000 000
Last Funding Date:
2020-12-14